MXCT
(NASDAQ)MaxCyte, Inc.
$1.38-- (--)
Loading... - Market loading
MaxCyte (MXCT) Stock Price & Financial Analysis
MaxCyte Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Day's Range$1.36 - $1.41
52-Week High$1.87
52-Week Low$0.64
Open$1.39
Volume611.07K
Average Volume (3M)949.71K
Market Cap147.49M
Shares Outstanding106.88M
Price to Sales (P/S)4.37
Price to Book (P/B)0.84
EV/EBITDA-4.40
Revenue (TTM)32.29M
Net Income (TTM)-39.12M
Free Cash Flow (TTM)-29.50M
EPS (TTM)$-0.37
Profit Margin-121.16%
Operating Margin-121.33%
Return on Equity (ROE)-23.30%
Debt to Equity0.10
50-Day MA$1.20
200-Day MA$1.14
52-Week Change-2.94%
Annual Dividend$0.00
Dividend Yield0.00%
Day's Range$1.36 - $1.41
52-Week High$1.87
52-Week Low$0.64
Open$1.39
Volume611.07K
Average Volume (3M)949.71K
Market Cap147.49M
Shares Outstanding106.88M
Price to Sales (P/S)4.37
Price to Book (P/B)0.84
EV/EBITDA-4.40
Revenue (TTM)32.29M
Net Income (TTM)-39.12M
Free Cash Flow (TTM)-29.50M
EPS (TTM)$-0.37
Profit Margin-121.16%
Operating Margin-121.33%
Return on Equity (ROE)-23.30%
Debt to Equity0.10
50-Day MA$1.20
200-Day MA$1.14
52-Week Change-2.94%
Annual Dividend$0.00
Dividend Yield0.00%
Frequently Asked Questions About MaxCyte
What is the current stock price for MXCT?
As of the latest trading session, MXCT stock trades at $1.38. The 52-week range is $0.64–$1.87, with a day range of $1.36–$1.41.
What is the P/E ratio for MXCT?
The P/E ratio (Price-to-Earnings) for MXCT is shown in the Key Statistics section. This valuation metric helps compare MaxCyte, Inc. to industry peers.
Does MXCT pay dividends?
MaxCyte does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for MXCT?
Based on 1 analyst, the consensus for MXCT is Buy.
What is the market cap of MXCT?
MaxCyte's market capitalization is $147.5M, classifying it as a micro-cap company. MaxCyte operates in the Healthcare sector within the Medical Devices industry.